Vitreous cytokine levels following the administration of a single 0.19 mg fluocinolone acetonide (ILUVIEN®) implant in patients with refractory diabetic macular edema (DME)—results from the ILUVIT study

被引：0
|
作者：
Svenja K. Deuchler
Ralf Schubert
Pankaj Singh
Adonis Chedid
Ninel Kenikstul
Julia Scott
Thomas Kohnen
Hanns Ackermann
Frank Koch
机构：
[1] Augenzentrum Frankfurt,Department of Ophthalmology
[2] Goethe University Hospital,Pneumological
[3] Goethe University Hospital,Immunological Laboratory
[4] Goethe University Hospital,Institute of Biostatistics
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2022年 / 260卷
关键词：
Cytokines; Diabetic macular edema; Diabetic retinopathy; Fluocinolone acetonide; Growth factors; Inflammatory markers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2537 / 2547
页数：10
相关论文
共 50 条
  • [11] The impact of vitrectomy on outcomes achieved with 0.19 mg fluocinolone acetonide implant in patients with diabetic macular edema
    Augustin, Albert J.
    Bopp, Silvia
    Fechner, Martin
    Holz, Frank G.
    Sandner, Dirk
    Winkgen, Andrea-M
    Khoramnia, Ramin
    Neuhann, Thomas
    Warscher, Markus
    Spitzer, Martin S.
    Sekundo, Walter
    Seitz, Berthold
    Duncker, Tobias
    Ksinsik, Christian
    Hoeh, Helmut
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2022, 32 (02) : 1101 - 1108
  • [12] Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review (vol 7, pg 293, 2018)
    Fusi-Rubiano, William
    Blow, Rebecca R.
    Lane, Mark
    Morjaria, Rupal
    Denniston, Alastair K.
    OPHTHALMOLOGY AND THERAPY, 2020, 9 (01) : 205 - 205
  • [13] Fluocinolone Acetonide (0.19 mcg/day) Intravitreal Implant and Improved Treatment Burden for Patients with Diabetic Macular Edema (DME)
    Byun, Matthew
    Riemann, Christopher D.
    Osher, James
    Patel, Yogin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [14] The 0.19-mg Fluocinolone Acetonide Implant for the Treatment of Diabetic Macular Edema: An Expert Consensus
    Kolomeyer, Anton M.
    Eichenbaum, David A.
    Kiernan, Daniel F.
    Suner, Ivan J.
    Hariprasad, Seenu M.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2023, 54 (03): : 166 - +
  • [15] Fluocinolone acetonide ( FAc) 0.2 mg intravitreal implant in the treatment of diabetic macular edema (DME)
    Liu, John
    Coney, Joseph
    Schartman, Jerome
    Miller, David G.
    Zegarra, Hernando
    Rao, Llewelyn
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [16] Real-World Outcomes of the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema
    Morozova, Christine
    Humayun, Lucas L.
    Kasper, Jonathan
    Morozov, Andy
    Tabandeh, Homayoun
    Boyer, David S.
    Dayani, Pouya N.
    Rahhal, Firas M.
    JOURNAL OF VITREORETINAL DISEASES, 2024, 8 (04) : 394 - 400
  • [17] The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema
    Merrill, Pauline T.
    Holekamp, Nancy
    Roth, Daniel
    Kasper, Jonathan
    Grigorian, Ruben
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2023, 248 : 16 - 23
  • [18] First real world analysis of safety in 0.19 mg fluocinolone acetonide (FAc, ILUVIEN) implant treated eyes receiving supplemental ocular steroid injection for diabetic macular edema (DME)
    Gonzalez, Victor H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [19] Optical Coherence Tomography Biomarkers - Vitreous Status Influence in Outcomes for Diabetic Macular Edema Therapy with 0.19 mg Fluocinolone Acetonide Implant
    Ferreira, Andre
    Oliveira Leite, Joao Miguel
    Melo-Beirao, Joao Nuno
    Meireles, Angelina
    Pessoa, Bernardete
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [20] Challenging Clinical Cases - A Walk Through Supplemental Therapy with Intravitreal Ranibizumab Therapy Following Treatment of Diabetic Macular Edema with the 0.19 mg Fluocinolone Acetonide Implant (ILUVIEN®)
    Pessoa, Bernardete
    Melo-Beirao, Joao
    Meireles, Angelina
    Meneres, Pedro
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2020, 13 : 437 - 448
12345